CONTINUE TO SITE

OR WAIT null SECS

COVID-19 Update Analytics Dosage Forms Drug Development Manufacturing Outsourcing Quality Systems

COVID-19 UpdateAnalyticsDosage FormsDrug DevelopmentManufacturingOutsourcingQuality Systems

View More Analytical Method Development APIs Aseptic Processing Biologic Drugs Drug Delivery Equipment Excipients Formulation Packaging Process Control/PAT Process Development QA/QC Regulatory Action Supply Chain

Analytical Method DevelopmentAPIsAseptic ProcessingBiologic DrugsDrug DeliveryEquipmentExcipientsFormulationPackagingProcess Control/PATProcess DevelopmentQA/QCRegulatory ActionSupply Chain

News

All News Top News Industry News Bio/Pharma News Supplier News News from Europe Events

All NewsTop NewsIndustry NewsBio/Pharma NewsSupplier NewsNews from EuropeEvents

Publications

All Publications PharmTech PharmTech Europe

All PublicationsPharmTechPharmTech Europe

Resources

Front & Center Pharma Insights Sponsored eBooks Sponsored Podcasts Sponsored Videos Whitepapers

Front & CenterPharma InsightsSponsored eBooksSponsored PodcastsSponsored VideosWhitepapers

Webcasts Marketplace

Enewsletters Magazine North America Magazine Europe

EnewslettersMagazine North AmericaMagazine Europe

About Us
Advertise
Contact Us
Editorial Info
Editorial Contacts
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

Spotlight

COVID-19 Update
Analytics
Dosage Forms
Drug Development
Manufacturing
Outsourcing
Quality Systems

TopicSee All >

Analytical Method Development
APIs
Aseptic Processing
Biologic Drugs
Drug Delivery
Equipment
Excipients
Formulation
Packaging
Process Control/PAT
Process Development
QA/QC
Regulatory Action
Supply Chain

About Us
Advertise
Contact Us
Editorial Info
Editorial Contacts
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions

Orally Disintegrating Tablets

May 3, 2013

Cynthia A. Challener

Podcast interview with Nick Johnson, Strategic Marketing Director for Modified Release Technologies at Catalent Pharma Solutions

Cellectis Opens GMP Manufacturing Facility

EMA Approves Two New Manufacturing Sites and a New Formulation for Comirnaty

EMA Starts Evaluation of Comirnaty in Children